We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-4.05%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.11B
AUM Growth
-$170M
Cap. Flow
-$54.7M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.5%
Holding
2,409
New
42
Increased
215
Reduced
756
Closed
94

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.75M
2
TSLA icon
Tesla
TSLA
+$1.84M
3
CSGP icon
CoStar Group
CSGP
+$1.61M
4
PCG icon
PG&E
PCG
+$1.12M
5
EQT icon
EQT Corp
EQT
+$955K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 13.97%
3 Financials 12.12%
4 Consumer Discretionary 10.21%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRWG icon
2226
GrowGeneration
GRWG
$111M
$12.6K ﹤0.01%
3,613
+2,704
+297% +$12.5K
PETQ
2227
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$12.6K ﹤0.01%
1,827
ABUS icon
2228
Arbutus Biopharma
ABUS
$906M
$12.6K ﹤0.01%
6,593
+4,768
+261% +$11.2K
DGICA icon
2229
Donegal Group Class A
DGICA
$692M
$12.6K ﹤0.01%
931
NDLS icon
2230
Noodles & Co
NDLS
$102M
$12.5K ﹤0.01%
334
+286
+596% +$11.4K
HLGN
2231
DELISTED
Heliogen, Inc.
HLGN
$12.5K ﹤0.01%
+193
New +$15.1K
CENN icon
2232
Cenntro
CENN
$8.33M
$12.5K ﹤0.01%
20
PAMT
2233
PAMT Corp
PAMT
$281M
$12.5K ﹤0.01%
+405
New +$12.9K
ALXO icon
2234
ALX Oncology
ALXO
$275M
$12.5K ﹤0.01%
+1,308
New +$15.2K
NEUE
2235
DELISTED
NeueHealth
NEUE
$12.5K ﹤0.01%
148
RIGL icon
2236
Rigel Pharmaceuticals
RIGL
$759M
$12.5K ﹤0.01%
1,055
+868
+464% +$11.7K
ABSI icon
2237
Absci
ABSI
$1.63B
$12.4K ﹤0.01%
3,959
HOV icon
2238
Hovnanian Enterprises
HOV
$797M
$12.4K ﹤0.01%
347
REI icon
2239
Ring Energy
REI
$349M
$12.4K ﹤0.01%
5,331
INSE icon
2240
Inspired Entertainment
INSE
$163M
$12.3K ﹤0.01%
1,398
ZYXI
2241
DELISTED
Zynex
ZYXI
$12.3K ﹤0.01%
+1,354
New +$11.8K
FOR icon
2242
Forestar Group
FOR
$1.49B
$12.3K ﹤0.01%
1,097
CMBM
2243
DELISTED
Cambium Networks
CMBM
$12.3K ﹤0.01%
+724
New +$13K
LXRX icon
2244
Lexicon Pharmaceuticals
LXRX
$1.05B
$12.2K ﹤0.01%
+5,094
New +$14.1K
GCBC icon
2245
Greene County Bancorp
GCBC
$600M
$12.2K ﹤0.01%
+426
New +$11.2K
ATRA icon
2246
Atara Biotherapeutics
ATRA
$75.8M
$12.2K ﹤0.01%
129
-98
-43% -$11K
CRGE
2247
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$12.1K ﹤0.01%
6,894
GLRE icon
2248
Greenlight Captial
GLRE
$511M
$12.1K ﹤0.01%
1,630
MN
2249
DELISTED
MANNING & NAPIER, INC.
MN
$12.1K ﹤0.01%
988
NGMS
2250
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$12.1K ﹤0.01%
939

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 Portfolio in Review

As of Q3 2022, Metropolitan Life Insurance Company (MetLife) held 2,409 positions worth $2.11B, down 7.5% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 filing shows 42 new, 215 increased, 756 reduced and 94 closed positions. Its largest new stake was CoStar Group: 23,153 shares worth $1.61M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2022 buy was CoStar Group: 23,153 shares worth $1.61M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $3.75M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $433K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.11B portfolio in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 42 new positions and closed 94 in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 7.5% quarter-over-quarter to $2.11B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.